Evidence map›Paper›PMID 40111503›Full record

ArticleEuropean journal of pediatrics2025

Phenotypic variability in cases with CACNA1A mutation.

Sema Bozkaya-Yilmaz, Nihal Olgac-Dundar, Nargiz Aliyeva, Atilla Ersen, Pinar Gencpinar, Mesut Gungor, Ayse Semra Hiz, Uluc Yis, Gamze Sarikaya-Uzan, Esra Sarigecili and 15 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Neural Correlates of Intellectual Dysfunction in Episodic Ataxia Type 2.Journal of clinical neurology (Seoul, Korea) · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Sema Bozkaya-YilmazDepartment of Pediatric Neurology, Bursa State Hospital, Bursa, Turkey. semabozkayayilmaz@gmail.com.ORCID http://orcid.org/0000-0002-5389-5616
Nihal Olgac-DundarDepartment of Pediatric Neurology, Faculty of Medicine, Katip Celebi University, Izmir, Turkey. nodundar@gmail.com.ORCID http://orcid.org/0000-0002-5902-3501
Nargiz AliyevaDepartment of Pediatric Neurology, Liv Bonadea Hospital, Baku, Azerbaijan.
Atilla ErsenDepartment of Pediatric Neurology, Private Clinic, Izmir, Turkey.
Pinar GencpinarDepartment of Pediatric Neurology, Faculty of Medicine, Katip Celebi University, Izmir, Turkey.
Mesut GungorDepartment of Pediatric Neurology, Faculty of Medicine, Selcuk University, Konya, Turkey.
Ayse Semra HizDepartment of Pediatric Neurology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Uluc YisDepartment of Pediatric Neurology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Gamze Sarikaya-UzanDepartment of Pediatric Neurology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Esra SarigeciliDepartment of Pediatric Neurology, Adana State Hospital, Adana, Turkey.
Serkan KirikDepartment of Pediatric Neurology, Faculty of Medicine, Firat University, Elazig, Turkey.
Ilknur ErolDepartment of Pediatric Neurology, Faculty of Medicine, Baskent University, Adana, Turkey.
Seyda BesenDepartment of Pediatric Neurology, Faculty of Medicine, Baskent University, Adana, Turkey.
Hulya KayiliogluDepartment of Pediatric Neurology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey.
Senay HaspolatDepartment of Pediatric Neurology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Osman KipogluDepartment of Pediatric Neurology, Mehmet Akif Training and Research Hospital, Sanliurfa, Turkey.
Arzu EkiciDepartment of Pediatric Neurology, Private Clinic, Bursa, Turkey.
Sevim TurayDepartment of Pediatric Neurology, Faculty of Medicine, Duzce University, Duzce, Turkey.
Ayse TosunDepartment of Pediatric Neurology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
Muge AyanogluDepartment of Pediatric Neurology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
Aysegul DanisDepartment of Pediatric Neurology, Faculty of Medicine, Abant Izzet Baysal University, Bolu, Turkey.
Fatma HancıDepartment of Pediatric Neurology, Faculty of Medicine, Abant Izzet Baysal University, Bolu, Turkey.
Yasar Bekir KutbayGenetic Diseases Diagnosis Center, Izmır State Hospital, Izmir, Turkey.
Berk OzyilmazGenetic Diseases Diagnosis Center, Izmır State Hospital, Izmir, Turkey.
Bulent KaraDepartment of Pediatric Neurology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to enhance understanding of CACNA1A gene variants by elucidating the clinical profiles of patients with different variants. The overlapping features and varying phenotypic characteristics of these neurological disorders pose challenges for clinicians. A data collection form was utilized to gather clinical features, examination details, and treatment information associated with CACNA1A variants. Thirty-one patients were included in the study from 11 different clinics in Turkey. Cases were assessed by comparing their information with existing literature. The study initially included 32 patients from 29 families, with 31 patients meeting the inclusion criteria. Clinical manifestations ranged from congenital onset hypotonia to motor seizures. Within the group of patients, 87% were diagnosed with epilepsy, 61% had neurodevelopmental defects, 32% experienced ataxia, 22% had eye movement problems, 16% suffered from migraines, and 13% had recurrent encephalopathy. Thirty percent of individuals exhibited cerebellar atrophy. A subset of individuals exhibited various forms of cognitive impairment and different kinds of ataxia.

conclusionCACNA1A variants can lead to structural and functional abnormalities in the Cav2.1 channels, resulting in paroxysmal and/or chronic clinical presentations. The overlapping phenotypes and variable features among family members suggest the influence of environmental factors and modifier genes. A thorough understanding of the range of phenotypic variants and the difficulties encountered by medical professionals is essential for precise diagnosis and efficient treatment approaches in various neurological conditions. Additional research is necessary to clarify the underlying mechanisms that contribute to the various presentations of these variants. WHAT IS KNOWN: • Variants in the CACNA1A gene disrupt calcium signaling, thereby impacting fundamental developmental processes such as neuronal differentiation, migration, and synapse formation. • Variants in the CACNA1A can lead to neurodevelopmental disorders characterized by intellectual disability, learning difficulties, memory challenges, and problems in social interaction. WHAT IS NEW: • Instances of intrafamilial variability in CACNA1A variants have been identified, with differing clinical manifestations exhibited by affected family members. • Incomplete penetrance is a phenomenon that may occur, as neurodevelopmental or neuropsychiatric findings are not exhibited by some patients with CACNA1A variants.

Indexed as

Calcium ChannelsMutationNeurodevelopmental DisordersAdolescentAdultCalcium Channels, N-TypeChildChild, PreschoolEpilepsyFemaleHumansInfantMaleMigraine DisordersPhenotypeTurkeyCACNA1A protein, humanCalcium ChannelsCalcium Channels, N-TypeCACNA1AEpilepsyGeneticNeurodevelopmental disorder

Identifiers

PMID40111503
PMCPMC11926052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.